FDA.reportPublic FDA data

denosumab-qbde 120 MG in 1.7 ML Injection

RxCUI
2725590
RxNorm name
denosumab-qbde 120 MG in 1.7 ML Injection
Display name
denosumab-qbde 120 MG in 1.7 ML Injection
Full name
denosumab-qbde 120 MG in 1.7 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761439Enobydenosumab-qbde351(k) InterchangeableRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XTRENBODENOSUMAB-QBDEHikma Pharmaceuticals USA Inc.a48a3a33-6b0e-4cf4-8786-8f662d6ee77b2025-09-02Warnings, Adverse reactionsExact identifier
rxcui: 2725590

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a48a3a33-6b0e-4cf4-8786-8f662d6ee77bdenosumab-qbde 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab-qbde 70 MG/ML Injection [SCD] · denosumab-qbde 120 MG per 1.7 ML Injection [SY]32These highlights do not include all the information needed to use XTRENBO™ safely and effectively. See full prescribing information for XTRENBO. XTRENBO™ (denosumab-qbde) injection, for subcutaneous use Initial U.S. Approval: 2025 XTRENBO™ (denosumab-qbde) is biosimilar* to XGEVA ® (denosumab).20250902